Sutro Biopharma, Inc. · NASDAQ:STRO
BVF PARTNERS L P/IL reported a 7.60% stake in Sutro Biopharma, Inc. (Schedule 13G)
Event Feb 10, 2026 · Filed Feb 18, 2026
BVF PARTNERS L P/IL reported a 7.60% stake in Sutro Biopharma, Inc., 1,251,788 shares, as a passive investor on Feb 10, 2026. Filed Feb 18, 2026 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 1,251,788
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.10% | 668,693 |
| BVF I GP LLC | 4.10% | 668,693 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.00% | 488,916 |
| BVF II GP LLC | 3.00% | 488,916 |
| Biotechnology Value Trading Fund OS LP | 0.50% | 75,359 |
| BVF Partners OS Ltd. | 0.50% | 75,359 |
| BVF GP HOLDINGS LLC | 7.00% | 1,157,609 |
| BVF PARTNERS L P/IL | 7.60% | 1,251,788 |
| BVF INC/IL | 7.60% | 1,251,788 |
| LAMPERT MARK N | 7.60% | 1,251,788 |
Source
Related
- Sutro Biopharma, Inc.
- Bvf Partners L P
- Sutro Biopharma, Inc. shareholders
- Form 4 · Gerber Hans-Peter · Sep 22, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026